Plain Language Summary on Safety and Efficacy of Damoctocog Alfa Pegol in Previously Treated Children Aged 7 to < 12 Years With Severe Haemophilia A in the Phase 3, Open Label Alfa-PROTECT Main Study.

Margareth C Ozelo, Matteo Luciani, Heidi Glosli, Kaan Kavakli, Nasrin Samji, Gregory C Makris, Claudia Tueckmantel, Monika Maas Enriquez, Luciana C Oliveira, Shveta Gupta, Mario Guillermo Arbesú, Mauro Davoli, Anthony K C Chan, Maria Elisa Mancuso